Drugs, Key Data 2013
OFDT, 8 p.
The purpose of this publication is to periodically collect the most recent and most relevant key quantitative indicators of drug use, whether illegal substances, tobacco, alcohol or psychotropic medicines. These data constitute a common foundation of knowledge on which public authority actions are based, coordinated by the French Interministerial Mission for the Fight against Drugs and Drug Addiction (MILDT) placed under the authority of the Prime Minister.
This document, prepared by the French Monitoring Centre for Drugs and Drug Addiction (OFDT), relies on its own research as well as the work of other institutions. First and foremost, it summarises for the main substances the levels of use observed in the French population as a whole. Then, it provides detailed information on use, treatment, health and social consequences as well as trafficking data per product. When possible, trends in these areas are provided.
Drugs in Europe
What do the latest data tell us about the European drug market? What are the new trends in drug use among European adults and school students? What are the harms associated with drug use and what is being done to counter them? These and other questions are explored in the 2019 EMCDDA European Drug Report.
Country drug reports 2019
Developed by the EMCDDA, in cooperation with the Reitox national focal points, these graphic-rich reports cover: drug use and public health problems; drug policy and responses and drug supply.
The European Union and the drug phenomenon
The European Union & the drug phenomenon : Frequently asked questions, joint publication between the EMCDDA and the European Commission, october 2010, 12 p.